SymPhysis Medical

SymPhysis Medical is a private, clinical-stage medical device company developing the releaze™ Drainage System for managing malignant pleural effusion (MPE), a debilitating complication of late-stage cancers. The company's technology emphasizes intuitive one-touch control and a novel port design, aiming to streamline drainage and improve patient quality of life at home. Having secured numerous innovation awards, SymPhysis is preparing for regulatory submission to the FDA in 2026 and appears to be in a pre-revenue, fundraising stage as it advances toward commercialization.

Patient-centric indwelling pleural catheter system featuring one-touch activation, novel port-like access, and a streamlined dressing protocol for at-home management of malignant pleural effusions.

The competitive landscape includes established medical device companies offering traditional indwelling pleural catheters (e.g., Denver Pleural Effusion Shunt, Rocket Medical's PleurX). SymPhysis aims to differentiate through superior patient-centric design focused on intuitive, independent use, potentially disrupting the standard of care for ambulatory drainage.